Finzati - Logo
REX logo

REX American Resources Corporation

REX • Chemicals
$41.46
▼ -0.16 (-0.38%)
Current price
EarningsSep 3, 11:07 AM UTC
New financial eventQ2 2026Positive

REX American Resources Corporation has reported Q2 2026 financial results

The latest report is predominantly positive and shows an overall improvement in financial performance. Revenue and profitability advanced at a meaningful pace, while the weaker areas should be reviewed in context. The report may attract increased investor attention and price volatility.

Finzati signal
Positive development
Sep 3, 11:07 AM UTC
Improved
+17.87%
Revenue
Improved
+391.41%
Net income
Improved
+22.25%
Cash
Changed
+146.25%
Total debt
What changed
↑Revenue increased 17.9% versus the comparable prior period, indicating stronger top-line growth.
↑Net income increased 391.4%, showing improved profitability.
↑Total debt increased 146.3%, which may reduce financial flexibility.
↑Cash and short-term investments increased 22.2%.
Based on newly processed financial statements and comparable prior-period data.This is informational analysis, not investment advice.
Financial data as of: Jul 31, 2026, 12:00 AM UTCLast earnings update: Sep 3, 2026, 11:07 AM UTCLast profile update: Sep 4, 2026, 12:10 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$41.46
Change-0.38%
Shares Out33.09M
Market Cap$1.37B
Enterprise Value$1.01B
52W Range30.02 - 53.36
Beta0.63
P/E11.38
P/S2.00
P/B2.04
P/FCF20.01
EV/Sales1.48

Investment DNA

How strong this company looks for long-term investors

64
out of 100
Business Quality
Margins, moat, returns
67/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
80/100
Why this score▼
Stable or improving margins · 12.8%Positive free cash flow · 1.49Consistent free cash flow · 4/5Reasonable earnings multiple · 13.54Manageable debt level · 0.03Healthy liquidity · 5.94

Analyst view

Analyst sentiment and price target

REX
Analyst sentiment
Based on 3 analyst votes · 2026-09-05
100/100
Bullish
Bullish
3
Hold
0
Bearish
0
Price Target
2026-09-04
Low
$60.00
Mean
$60.00
Median
$60.00
High
$60.00

Company Overview

IPO: 7/17/1984
Industry: Chemicals
P/B i: 2.04
Debt / Equity i: 0.03
Operating Margin: 9.39%
Net Margin: 12.75%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.03
Current Ratio: 5.94
Quick Ratio: 5.56
Status: Good

Insider Transactions

Recent executive and insider activity

ROSE STUART A
Transaction: 06/18/2026
SELL
Change
-15,186
Price
$43.64
Filing
06/22/2026
Type
SELL
ROSE STUART A
Transaction: 06/17/2026
SELL
Change
-69,335
Price
$43.77
Filing
06/18/2026
Type
SELL
ROSE STUART A
Transaction: 06/15/2026
BUY
Change
+23,064
Price
Not reported
Filing
06/17/2026
Type
BUY